POST-TRANSPLANT USE OF AZATHIOPRINE AND PREDNISONE IS A PROGNOSTIC INDICATOR OF HEPATIC STEATOSIS IN LIVER TRANSPLANT PATIENTS

被引:0
|
作者
Lee, David Uihwan [1 ]
Daid, Sarav [2 ]
Mittal, Akaash [2 ]
Hastie, David [2 ]
Chadha, Bhawneet [2 ]
Fan, Gregory [3 ]
Malik, Raza [2 ]
机构
[1] Tufts Med Ctr, Ctr Liver, Boston, MA 02111 USA
[2] Tufts Med Ctr, Gastroenterol & Hepatol, Boston, MA 02111 USA
[3] Tufts Med Ctr, Boston, MA 02111 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1513
引用
收藏
页码:898A / 899A
页数:2
相关论文
共 50 条
  • [31] The impact of pre-transplant treatment on post-transplant outcomes in liver transplant patients with hepatocellular carcinoma
    Shimada, Shingo
    Kitajima, Toshihiro
    Shamaa, Tayseer
    Ivanics, Tommy
    Adhnan, Mohamed
    Moonka, Dilip
    Collins, Kelly
    Rizzari, Michael
    Yoshida, Atsushi
    Abouljoud, Marwan
    Nagai, Shunji
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 87 - 87
  • [32] Predictors of Post-Transplant Cardiac Dysfunction in Liver Transplant Recipients
    Mittal, C.
    Singla, S.
    Qureshi, W.
    Hassan, S.
    Huang, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 118 - 118
  • [33] Post-transplant lymphoproliferative syndrome in the pediatric liver transplant population
    Molmenti, EP
    Nagata, DE
    Roden, JS
    Squires, RH
    Molmenti, H
    Fasola, CG
    Winick, N
    Tomlinson, G
    Lopez, MJ
    D'Amico, L
    Dyer, HL
    Savino, AC
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Andersen, JA
    Klintmalm, GB
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (04) : 356 - 359
  • [34] The impact of post-transplant diabetes mellitus on liver transplant outcomes
    Lieber, Sarah R.
    Lee, Ruth-Ann
    Jiang, Yue
    Reuter, Claire
    Watkins, Randall
    Szempruch, Kristen
    Gerber, David A.
    Desai, Chirag S.
    DeCherney, G. Stephen
    Barritt, A. Sidney
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [35] Mycophenolate mofetil, microemulsion cyclosporine, and prednisone immunotherapy reduces post-transplant rejection in pediatric liver transplant recipients.
    Renz, JF
    Frankel, W
    Ferrell, LD
    Roberts, JP
    Emond, JC
    Ascher, NL
    Rosenthal, P
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 46A - 46A
  • [36] The risk of post-transplant recurrent immunoglobulin A nephropathy: the association with post-transplant steroid use
    Ohrstrom, Mette Thrane
    Schultz, Michael Dyrehauge
    Bistrup, Claus
    Birn, Henrik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [37] Mycophenolate mofetil, microemulsion cyclosporine, and prednisone immunotherapy reduces post-transplant rejection in pediatric liver transplant recipients.
    Renz, JF
    Rosenthal, P
    Frankel, W
    Ferrell, LD
    Roberts, JP
    Ascher, NL
    Emond, JC
    HEPATOLOGY, 1997, 26 (04) : 428 - 428
  • [38] Post-transplant outcomes of liver transplant recipients with hepatic sarcoidosis: a matched case-control study
    Udompap, P.
    Dilmaghani, S.
    Rosen, C.
    Watt, K.
    TRANSPLANTATION, 2023, 107 (09) : 151 - 152
  • [39] The risk of post-transplant recurrent immunoglobulin A nephropathy: the association with post-transplant steroid use
    Ohrstrom, Mette Thrane
    Schultz, Michael Dyrehauge
    Bistrup, Claus
    Birn, Henrik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I318 - I318
  • [40] Liver transplant in patients with HIV: Infection risk associated with HIV and post-transplant immunosuppression
    Viale P.
    Baccarani U.
    Tavio M.
    Current Infectious Disease Reports, 2008, 10 (1) : 74 - 81